Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

about

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

Item

http://www.wikidata.org/entity/Q47384845

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@en

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@nl

type

Item

label

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@en

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@nl

prefLabel

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@en

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@nl

P1476

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

@en

P2093

Ian Diner

http://www.w3.org/2001/XMLSchema#string

Nicholas T Seyfried

http://www.w3.org/2001/XMLSchema#string

Tram Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro

Measurement of protein using bicinchoninic acid

Neuropathological stageing of Alzheimer-related changes

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Protein aggregation and neurodegenerative disease

Proteomic screening for amyloid proteins

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Biochemical characterization of the core structure of alpha-synuclein filaments.

U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.

Toxic proteins in neurodegenerative disease.

P31

scholarly article

P356

10.3791/55835

http://www.w3.org/2001/XMLSchema#string

P433

128

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29155708

http://www.w3.org/2001/XMLSchema#string

P932

5755167

http://www.w3.org/2001/XMLSchema#string